FIELD: biochemistry.
SUBSTANCE: invention relates to a polypeptide for inducing an immune response against Chlamydia trachomatis, as well as to a nucleic acid coding it. Also disclosed is a pharmaceutical composition for preventive or therapeutic use against C. trachomatis infections containing said polypeptide or nucleic acid. Invention also relates to a method for preventing or treating Chlamydia trachomatis infection involving use of said composition.
EFFECT: invention enables effective inducing an immune response to Chlamydia trachomatis.
19 cl, 16 dwg, 8 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOACTIVE POLYPEPTIDES FOR IMPROVING PROTECTION, GROWTH AND PRODUCTIVITY OF PLANT | 2018 |
|
RU2772730C2 |
| POLYPEPTIDE CONSTRUCTIONS LYSINE-ANTIMICROBIAL PEPTIDE (AMP), LYSINES, ISOLATED ENCODING POLYNUCLEOTIDES AND VARIANTS OF THEIR APPLICATION | 2019 |
|
RU2803121C2 |
| ANTI-CLL1-SPECIFIC SINGLE-CHAIN CHIMERIC ANTIGENIC RECEPTORS (SCCAR) FOR CANCER IMMUNOTHERAPY | 2016 |
|
RU2731543C2 |
| INDUCIBLE CHIMERIC CYTOKINE RECEPTORS | 2019 |
|
RU2826155C2 |
| CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS TARGETING DLL3 | 2020 |
|
RU2822366C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY SPECIFICALLY BINDING WITH THE N-TERMINAL OF LYSYL-TRNA SYNTHETASE AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF DISEASES CAUSED BY CELL MIGRATION | 2018 |
|
RU2749591C1 |
| SELF-ASSEMBLED NANOSTRUCTURED VACCINES | 2019 |
|
RU2811439C2 |
| ISOLATION OF A NEW PESTIVIRUS CAUSING CONGENITAL TREMOR A | 2017 |
|
RU2765658C2 |
| THERAPEUTIC ANTI-CANCER NEOEPITOPE VACCINE | 2017 |
|
RU2782422C2 |
| IMMUNOTHERAPY CELLS DESIGNED FOR TARGETING ANTIGEN PRESENT SIMULTANEOUSLY ON IMMUNE CELLS AND ON PATHOLOGICAL CELLS | 2015 |
|
RU2714258C2 |
